|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.57 INR | -0.86% |
|
-2.12% | -40.39% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Pharmaceuticals Products | 15.43B | 16.69B | 15.24B | 16.85B | 16.7B | |||||
Total Assets | 24.71B | 23.91B | 21.89B | 21.91B | 20.47B | |||||
Interest Expense | -858M | -699M | -828M | -896M | -771M | |||||
Income Tax Expense | -115M | 90.34M | -182M | 133M | -479M | |||||
CAPEX | -312M | -250M | -301M | -294M | -438M | |||||
EBT | -595M | 341M | -424M | 183M | -1.62B | |||||
D&A | 603M | 570M | 591M | 607M | 624M | |||||
Net Income | -733M | 250M | -242M | 49.95M | -1.14B |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 9.66B | 11.81B | 8.45B | 11.46B | 11.72B | |||||
Outside India | 7.98B | 7.45B | 9.01B | 7.79B | 7.37B |
- Stock Market
- Stocks
- NECLIFE Stock
- Financials Nectar Lifesciences Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
